首页> 外国专利> PHARMACEUTICAL COMPOSITON FOR THE TREATMENT OF POSTHEPATECTOMY LIVER FAILURE AND DISORDER SYMPTOM COMPRISING TERLIPRESSIN OR THE COMBINATION THEREOF

PHARMACEUTICAL COMPOSITON FOR THE TREATMENT OF POSTHEPATECTOMY LIVER FAILURE AND DISORDER SYMPTOM COMPRISING TERLIPRESSIN OR THE COMBINATION THEREOF

机译:药物组合物,用于治疗肝硬化后肝功能衰竭和包含特利加压素或其组合的疾病症状

摘要

The present invention relates to the complication occurred after the liver function and liver function energy barrier as effective component of a kind of compound terlipressin including terlipressin or therapeutic agent effectively to be operated. Or a kind of pharmaceutical composition of terlipressin, influence treatment posthepatectomy liver failures or small size including the compound terlipressin as active constituent, it can be with the generation of complications after orthotopic liver transplantation, and influences the recovery of liver function or promote to restore. ;The 2015 of copyright KIPO submissions
机译:本发明涉及作为有效地操作的包括特利加压素或治疗剂的一种化合物特利加压素的有效成分,在肝功能和肝功能能量屏障后发生的并发症。或特利加压素的一种药物组合物,影响治疗肝切除术后的肝功能衰竭或以化合物特利加压素为活性成分的小体积,原位肝移植后可能伴随并发症的发生,并影响肝功能的恢复或促进恢复。 ; 2015年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号